β-Arrestin2 mediates the initiation and progression of myeloid leukemia

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 31, 2012, Pages 12532-12537

  Fereshteh, Mark ^a,b   Ito, Takahiro ^a   Kovacs, Jeffrey J ^b   Zhao, Chen ^b   Kwon, Hyog Young ^a   Tornini, Valerie ^b   Konuma, Takaaki ^a   Chen, Minyong ^b   Lefkowitz, Robert J ^b   Reya, Tannishtha ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chronic myeloid leukemia; Hematopoiesis; Leukemia stem cell

Indexed keywords

BCR ABL PROTEIN; BETA ARRESTIN 2; BETA CATENIN; LENTIVIRUS VECTOR; SHORT HAIRPIN RNA;

ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; BLAST CELL CRISIS; BONE MARROW; CANCER STEM CELL; CELL RENEWAL; CHEMOTAXIS; CHRONIC MYELOID LEUKEMIA; DISEASE COURSE; DRUG TARGETING; HEMATOPOIETIC SYSTEM; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN EXPRESSION; REGULATORY MECHANISM; T LYMPHOCYTE; WNT SIGNALING PATHWAY;

ANIMALS; ARRESTINS; BLAST CRISIS; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; MICE; MICE, KNOCKOUT; MUTATION; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; WNT SIGNALING PATHWAY;

EID: 84864507841     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1209815109     Document Type: Article

References (42)

1. Gorre ME, et al. (2001) Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification. Science 293:876-880. (Pubitemid 32743979)
2. Azam M, Latek RR, Daley GQ (2003) Mechanisms of autoinhibition and STI-571/imatinib resistance revealed by mutagenesis of BCR-ABL. Cell 112:831-843. (Pubitemid 36378885)
3. O'Hare T, Corbin AS, Druker BJ (2006) Targeted CML therapy: Controlling drug resistance, seeking cure. Curr Opin Genet Dev 16:92-99. (Pubitemid 43089618)
4. Graham SM, et al. (2002) Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. Blood 99:319-325.
5. Hu Y, et al. (2006) Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice. Proc Natl Acad Sci USA 103:16870-16875. (Pubitemid 44737345)
6. Jørgensen HG, Allan EK, Jordanides NE, Mountford JC, Holyoake TL (2007) Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells. Blood 109:4016-4019. (Pubitemid 46641755)
7. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ (1990) Beta-Arrestin: A protein that regulates beta-adrenergic receptor function. Science 248:1547-1550.
8. Attramadal H, et al. (1992) Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem 267:17882-17890.
9. DeWire SM, et al. (2008) Beta-arrestin-mediated signaling regulates protein synthesis. J Biol Chem 283:10611-10620.
10. Kovacs JJ, Hara MR, Davenport CL, Kim J, Lefkowitz RJ (2009) Arrestin development: Emerging roles for beta-arrestins in developmental signaling pathways. Dev Cell 17:443-458.
11. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK (2007) Beta-arrestins and cell signaling. Annu Rev Physiol 69:483-510.
12. Chen W, et al. (2003) Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Science 301:1391-1394. (Pubitemid 37075817)
13. Wilbanks AM, et al. (2004) Beta-arrestin 2 regulates zebrafish development through the hedgehog signaling pathway. Science 306:2264-2267. (Pubitemid 40024465)
14. Meloni AR, et al. (2006) Smoothened signal transduction is promoted by G protein-coupled receptor kinase 2. Mol Cell Biol 26:7550-7560. (Pubitemid 44547705)
15. Kovacs JJ, et al. (2008) Beta-arrestin-mediated localization of smoothened to the primary cilium. Science 320:1777-1781. (Pubitemid 351931292)
16. Zhao C, et al. (2007) Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo. Cancer Cell 12:528-541. (Pubitemid 350199070)
17. Zhao C, et al. (2009) Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature 458:776-779.
18. Reya T, et al. (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423:409-414. (Pubitemid 36626987)
19. Dierks C, et al. (2008) Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell 14:238-249.
20. Su Y, et al. (2005) Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models. J Immunol 175:5396-5402. (Pubitemid 41456426)
21. Fong AM, et al. (2002) Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc Natl Acad Sci USA 99:7478-7483. (Pubitemid 34568716)
22. Daley GQ, Van Etten RA, Baltimore D (1990) Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247:824-830.
23. Bryja V, Gradl D, Schambony A, Arenas E, Schulte G (2007) Beta-arrestin is a necessary component of Wnt/beta-catenin signaling in vitro and in vivo. Proc Natl Acad Sci USA 104:6690-6695. (Pubitemid 47175562)
24. Melo JV, Barnes DJ (2007) Chronic myeloid leukaemia as a model of disease evolution in human cancer. Nat Rev Cancer 7:441-453. (Pubitemid 46823444)
25. Advani AS, Pendergast AM (2002) Bcr-Abl variants: Biological and clinical aspects. Leuk Res 26:713-720. (Pubitemid 34628369)
26. Mayotte N, Roy DC, Yao J, Kroon E, Sauvageau G (2002) Oncogenic interaction between BCR-ABL and NUP98-HOXA9 demonstrated by the use of an in vitro purging culture system. Blood 100:4177-4184. (Pubitemid 35396886)
27. Dash AB, et al. (2002) A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9. Proc Natl Acad Sci USA 99:7622-7627. (Pubitemid 34568741)
28. Cuenco GM, Ren R (2001) Cooperation of BCR-ABL and AML1/MDS1/EVI1 in blocking myeloid differentiation and rapid induction of an acute myelogenous leukemia. Oncogene 20:8236-8248. (Pubitemid 34038211)
29. Yamamoto K, Nakamura Y, Saito K, Furusawa S (2000) Expression of the NUP98/HOXA9 fusion transcript in the blast crisis of Philadelphia chromosome-positive chronic myelogenous leukaemia with t(7;11)(p15;p15). Br J Haematol 109:423-426. (Pubitemid 30350728)
30. Ahuja HG, Popplewell L, Tcheurekdjian L, Slovak ML (2001) NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia. Genes Chromosomes Cancer 30:410-415. (Pubitemid 32216333)
31. Neering SJ, et al. (2007) Leukemia stem cells in a genetically defined murine model of blast-crisis CML. Blood 110:2578-2585. (Pubitemid 47523181)
32. Yue R, et al. (2009) Beta-arrestin1 regulates zebrafish hematopoiesis through binding to YY1 and relieving polycomb group repression. Cell 139:535-546.
33. Lakshmikanthan V, et al. (2009) Identification of betaArrestin2 as a corepressor of androgen receptor signaling in prostate cancer. Proc Natl Acad Sci USA 106:9379-9384.
34. Rosanò L, et al. (2009) Beta-arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc Natl Acad Sci USA 106:2806-2811.
35. Jamieson CH, et al. (2004) Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351:657-667. (Pubitemid 39063268)
36. Wang Y, et al. (2010) The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML. Science 327:1650-1653.
37. Tickenbrock L, et al. (2008) Activation of Wnt signalling in acute myeloid leukemia by induction of Frizzled-4. Int J Oncol 33:1215-1221.
38. Yeung J, et al. (2010) β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells. Cancer Cell 18:606-618.
39. Chen W, et al. (2004) Activity-dependent internalization of smoothened mediated by beta-arrestin 2 and GRK2. Science 306:2257-2260. (Pubitemid 40024463)
40. Bohn LM, et al. (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science 286:2495-2498.
41. Conner DA, et al. (1997) beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ Res 81:1021-1026. (Pubitemid 27514952)
42. Wu M, et al. (2007) Imaging hematopoietic precursor division in real time. Cell Stem Cell 1:541-554. (Pubitemid 350056405)